David L. Marcus

1.3k total citations
31 papers, 1.0k citations indexed

About

David L. Marcus is a scholar working on Molecular Biology, Physiology and Hematology. According to data from OpenAlex, David L. Marcus has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Physiology and 5 papers in Hematology. Recurrent topics in David L. Marcus's work include Alzheimer's disease research and treatments (7 papers), Porphyrin Metabolism and Disorders (6 papers) and Diet and metabolism studies (5 papers). David L. Marcus is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Porphyrin Metabolism and Disorders (6 papers) and Diet and metabolism studies (5 papers). David L. Marcus collaborates with scholars based in United States, Chile and Cuba. David L. Marcus's co-authors include Michael L. Freedman, Jir S. Tsai, C. Thomas, William H. Frey, Nader G. Ibrahim, Susana Masiá, Salman Hussain, D. Craig Miller, Jonathan Rosman and Miguel Llanos and has published in prestigious journals such as Nature Biotechnology, Annals of Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

David L. Marcus

30 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Marcus United States 16 455 374 155 116 112 31 1.0k
Tanuja Koppal United States 13 456 1.0× 491 1.3× 123 0.8× 181 1.6× 110 1.0× 15 1.1k
Enrico Brignardello Italy 19 389 0.9× 427 1.1× 101 0.7× 112 1.0× 115 1.0× 37 1.5k
Maria Sapienza Italy 10 494 1.1× 655 1.8× 105 0.7× 117 1.0× 168 1.5× 10 1.4k
Leonidas Lyras Greece 10 385 0.8× 333 0.9× 91 0.6× 79 0.7× 99 0.9× 13 887
Huanling Yu China 26 490 1.1× 495 1.3× 86 0.6× 112 1.0× 63 0.6× 71 1.5k
Antonella Vitali Italy 12 779 1.7× 480 1.3× 244 1.6× 133 1.1× 155 1.4× 16 1.1k
Hanna Bielarczyk Poland 22 403 0.9× 407 1.1× 118 0.8× 109 0.9× 240 2.1× 49 1.1k
L. Puglisi Italy 23 295 0.6× 333 0.9× 96 0.6× 71 0.6× 152 1.4× 66 1.3k
Brigitte Leininger‐Muller France 17 468 1.0× 417 1.1× 92 0.6× 141 1.2× 121 1.1× 29 1.3k
Cristina Grossi Italy 16 490 1.1× 379 1.0× 136 0.9× 163 1.4× 168 1.5× 17 1.1k

Countries citing papers authored by David L. Marcus

Since Specialization
Citations

This map shows the geographic impact of David L. Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Marcus more than expected).

Fields of papers citing papers by David L. Marcus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Marcus. The network helps show where David L. Marcus may publish in the future.

Co-authorship network of co-authors of David L. Marcus

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Marcus. A scholar is included among the top collaborators of David L. Marcus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Marcus. David L. Marcus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swerdlow, Russell H., Mony J. de Leon, & David L. Marcus. (2021). Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects. Journal of Alzheimer s Disease Reports. 5(1). 135–141. 5 indexed citations
2.
Martiniuk, Frank, et al.. (2007). Apoptotic Gene Expression in Alzheimer's Disease Hippocampal Tissue. American Journal of Alzheimer s Disease & Other Dementias®. 22(4). 319–328. 47 indexed citations
3.
Marcus, David L., et al.. (2006). Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.. PubMed. 12(1). BR8–14. 49 indexed citations
4.
Ronco, Ana María, et al.. (2001). The mechanism for lindane-induced inhibition of steroidogenesis in cultured rat Leydig cells. Toxicology. 159(1-2). 99–106. 39 indexed citations
5.
Ronco, Ana María, David L. Marcus, Fernando Pardo‐Manuel de Villena, & Mario Suwalsky. (1998). In vitro effect of dieldrin on leydig cell morphology and steroidogenic function. 11(4). 299–307. 2 indexed citations
6.
Marcus, David L., D. Craig Miller, Susana Masiá, et al.. (1998). Quantitative neuronal c-Fos and c-Jun expression in Alzheimer’s disease. Neurobiology of Aging. 19(5). 393–400. 87 indexed citations
7.
Marcus, David L., et al.. (1998). Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's Disease. Experimental Neurology. 150(1). 40–44. 423 indexed citations
8.
Marcus, David L. & Michael L. Freedman. (1997). Decreased Brain Glucose Metabolism in Microvessels from Patients with Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 826(1). 248–253. 30 indexed citations
9.
Tsai, Jir S., et al.. (1996). Nocturnal Monitoring of Growth Hormone, Insulin, C-Peptide, and Glucose in Patients With Acromegaly. The American Journal of the Medical Sciences. 311(6). 281–285. 1 indexed citations
10.
Tsai, Jir S., et al.. (1996). Nocturnal Monitoring of Growth Hormone, Insulin, C-Peptide, and Glucose in Patients With Acromegaly. The American Journal of the Medical Sciences. 311(6). 281–285. 1 indexed citations
11.
Marcus, David L., et al.. (1990). Cimetidine Suppresses Chemically Induced Experimental Hepatic Porphyria. The American Journal of the Medical Sciences. 300(4). 214–217. 8 indexed citations
12.
Marcus, David L., Mony J. de Leon, Jeffrey Goldman, et al.. (1989). Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Annals of Neurology. 26(1). 91–94. 43 indexed citations
13.
Leon, Mony J. de, Ajax E. George, David L. Marcus, & Jeffrey D. Miller. (1988). Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease. Neurobiology of Aging. 9(1). 88–90. 4 indexed citations
14.
Marcus, David L., et al.. (1987). Low Serum B 12 Levels in a Hematologically Normal Elderly Subpopulation. Journal of the American Geriatrics Society. 35(7). 635–638. 38 indexed citations
15.
Marcus, David L. & Michael L. Freedman. (1985). Clinical Disorders of Iron Metabolism in the Elderly. Clinics in Geriatric Medicine. 1(4). 729–745. 8 indexed citations
16.
Marcus, David L., et al.. (1984). Effect of cimetidine on δ-aminolevulinic acid synthase and microsomal heme oxygenase in rat liver. Biochemical Pharmacology. 33(13). 2005–2008. 29 indexed citations
17.
Marcus, David L., Nader G. Ibrahim, & Michael L. Freedman. (1982). Age-related decline in the biosynthesis of mitochondrial inner membrane proteins. Experimental Gerontology. 17(5). 333–341. 27 indexed citations
18.
Finlay, Thomas H., et al.. (1981). Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets. Biochimica et Biophysica Acta (BBA) - General Subjects. 672(1). 79–88. 6 indexed citations
19.
Marcus, David L., et al.. (1979). Additive inhibition of in vitro rabbit reticulocyte heme and protein synthesis with combinations of isoniazid, chloramphenicol and ethanol. The American Journal of the Medical Sciences. 278(3). 207–216. 2 indexed citations
20.
Marcus, David L., Alan J. Johnson, & Thomas H. Finlay. (1978). Purification and properties of porcine platelet aggregating factor. Biochimica et Biophysica Acta (BBA) - Protein Structure. 537(1). 44–61. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanuja Koppal Breakdown of academic impact, for papers by Enrico Brignardello Breakdown of academic impact, for papers by Maria Sapienza Breakdown of academic impact, for papers by Leonidas Lyras Breakdown of academic impact, for papers by Huanling Yu Breakdown of academic impact, for papers by Antonella Vitali Breakdown of academic impact, for papers by Hanna Bielarczyk Breakdown of academic impact, for papers by L. Puglisi Breakdown of academic impact, for papers by Brigitte Leininger‐Muller Breakdown of academic impact, for papers by Cristina Grossi
Rankless by CCL
2026